Earth Science Tech (ETST) Non Operating Investment Income (2024 - 2026)
Earth Science Tech's (ETST) quarterly Non Operating Investment Income came in at $365537.0 in Q2 2026, up 170.14% on a YoY basis from $135316.0 in Q2 2025, and up 124.47% quarter-over-quarter from -$1.5 million in Q1 2026.
Analysis
Earth Science Tech (ETST) Non Operating Investment Income (2024 - 2026) Analysis & Trends
Earth Science Tech (ETST) has reported Non Operating Investment Income for 3 consecutive years, with $365537.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Investment Income rose 170.14% year-over-year to $365537.0; the trailing twelve-month figure through Jun 2026 stood at -$1.5 million (changed N/A YoY), and the FY2026 full-year result was -$957118.0, down 161.75% from the prior year.
- Non Operating Investment Income advanced to $365537.0 in Q2 2026 per ETST's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $365537.0 in Q2 2026 and bottomed at -$1.5 million in Q1 2026.
- Historically, Non Operating Investment Income has averaged -$250894.1 across 3 years, with a median of -$168384.0 in 2025.
- The widest YoY moves for Non Operating Investment Income: up 170.14% in 2026, down 787.3% in 2026.
- Over 3 years, Non Operating Investment Income stood at -$197277.0 in 2024, then tumbled by 211.11% to -$613741.0 in 2025, then soared by 159.56% to $365537.0 in 2026.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered $365537.0, -$1.5 million, and -$613741.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | - |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn | 365,537.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 365,537.00 |
| Mar 31, 2026 | -1.49 Mn |
| Dec 31, 2025 | -613,741.00 |
| Sep 30, 2025 | 216,359.00 |
| Jun 30, 2025 | 135,316.00 |
| Mar 31, 2025 | -168,384.00 |
| Dec 31, 2024 | -197,277.00 |